Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

OSL:CRAYN - Euronext Oslo - NO0010808892 - Common Stock - Currency: NOK

114.2  +0.7 (+0.62%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRAYN. CRAYN was compared to 101 industry peers in the Software industry. While CRAYN is still in line with the averages on profitability rating, there are concerns on its financial health. CRAYN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
In the past year CRAYN had a positive cash flow from operations.
CRAYN had positive earnings in 4 of the past 5 years.
CRAYN had a positive operating cash flow in each of the past 5 years.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

CRAYN has a Return On Assets of 1.31%. This is comparable to the rest of the industry: CRAYN outperforms 47.47% of its industry peers.
CRAYN has a Return On Equity of 8.68%. This is comparable to the rest of the industry: CRAYN outperforms 59.60% of its industry peers.
With an excellent Return On Invested Capital value of 11.40%, CRAYN belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRAYN is below the industry average of 11.53%.
The last Return On Invested Capital (11.40%) for CRAYN is above the 3 year average (8.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.31%
ROE 8.68%
ROIC 11.4%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CRAYN has a Profit Margin (3.67%) which is in line with its industry peers.
CRAYN's Profit Margin has declined in the last couple of years.
CRAYN has a Operating Margin of 11.44%. This is in the better half of the industry: CRAYN outperforms 65.66% of its industry peers.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
Looking at the Gross Margin, with a value of 89.60%, CRAYN belongs to the top of the industry, outperforming 86.87% of the companies in the same industry.
CRAYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.44%
PM (TTM) 3.67%
GM 89.6%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRAYN is still creating some value.
Compared to 1 year ago, CRAYN has about the same amount of shares outstanding.
CRAYN has more shares outstanding than it did 5 years ago.
CRAYN has a better debt/assets ratio than last year.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.93, we must say that CRAYN is in the distress zone and has some risk of bankruptcy.
CRAYN has a worse Altman-Z score (0.93) than 69.70% of its industry peers.
The Debt to FCF ratio of CRAYN is 1.71, which is an excellent value as it means it would take CRAYN, only 1.71 years of fcf income to pay off all of its debts.
CRAYN's Debt to FCF ratio of 1.71 is fine compared to the rest of the industry. CRAYN outperforms 73.74% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that CRAYN is somewhat dependend on debt financing.
The Debt to Equity ratio of CRAYN (0.55) is worse than 68.69% of its industry peers.
Even though the debt/equity ratio score it not favorable for CRAYN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.71
Altman-Z 0.93
ROIC/WACC1.33
WACC8.6%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.99 indicates that CRAYN may have some problems paying its short term obligations.
CRAYN has a Current ratio of 0.99. This is in the lower half of the industry: CRAYN underperforms 67.68% of its industry peers.
CRAYN has a Quick Ratio of 0.99. This is a bad value and indicates that CRAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRAYN has a worse Quick ratio (0.99) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

CRAYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 318.50%, which is quite impressive.
Measured over the past 5 years, CRAYN shows a small growth in Earnings Per Share. The EPS has been growing by 3.25% on average per year.
The Revenue has grown by 9.63% in the past year. This is quite good.
CRAYN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.43% yearly.
EPS 1Y (TTM)318.5%
EPS 3Y3.25%
EPS 5YN/A
EPS Q2Q%154.04%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%2.11%

3.2 Future

CRAYN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.49% yearly.
Based on estimates for the next years, CRAYN will show a decrease in Revenue. The Revenue will decrease by -1.25% on average per year.
EPS Next Y47.66%
EPS Next 2Y38.47%
EPS Next 3Y29.49%
EPS Next 5YN/A
Revenue Next Year13.41%
Revenue Next 2Y14.01%
Revenue Next 3Y13.73%
Revenue Next 5Y-1.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

CRAYN is valuated quite expensively with a Price/Earnings ratio of 40.21.
CRAYN's Price/Earnings ratio is a bit cheaper when compared to the industry. CRAYN is cheaper than 61.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of CRAYN to the average of the S&P500 Index (29.35), we can say CRAYN is valued slightly more expensively.
A Price/Forward Earnings ratio of 13.39 indicates a correct valuation of CRAYN.
Based on the Price/Forward Earnings ratio, CRAYN is valued cheaper than 89.90% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CRAYN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 40.21
Fwd PE 13.39
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRAYN indicates a rather cheap valuation: CRAYN is cheaper than 82.83% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CRAYN is valued cheaper than 93.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.9
EV/EBITDA 9.25
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CRAYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRAYN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRAYN's earnings are expected to grow with 29.49% in the coming years.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y38.47%
EPS Next 3Y29.49%

0

5. Dividend

5.1 Amount

No dividends for CRAYN!.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (3/7/2025, 7:00:00 PM)

114.2

+0.7 (+0.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-14 2025-05-14
Inst Owners63.5%
Inst Owner ChangeN/A
Ins Owners0.82%
Ins Owner ChangeN/A
Market Cap10.23B
Analysts82.67
Price Target143.67 (25.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.71%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-9.59%
Revenue beat(4)1
Avg Revenue beat(4)-5.61%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-2.62%
Revenue beat(12)5
Avg Revenue beat(12)-20%
Revenue beat(16)5
Avg Revenue beat(16)-36.3%
PT rev (1m)-5.62%
PT rev (3m)-5.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.7%
EPS NY rev (3m)-9.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.61%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE 40.21
Fwd PE 13.39
P/S 1.46
P/FCF 8.9
P/OCF 7.87
P/B 3.45
P/tB N/A
EV/EBITDA 9.25
EPS(TTM)2.84
EY2.49%
EPS(NY)8.53
Fwd EY7.47%
FCF(TTM)12.83
FCFY11.23%
OCF(TTM)14.5
OCFY12.7%
SpS78.29
BVpS33.06
TBVpS-10.97
PEG (NY)0.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 8.68%
ROCE 16.84%
ROIC 11.4%
ROICexc 17.46%
ROICexgc N/A
OM 11.44%
PM (TTM) 3.67%
GM 89.6%
FCFM 16.39%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.71
Debt/EBITDA 1.42
Cap/Depr 44.51%
Cap/Sales 2.14%
Interest Coverage 250
Cash Conversion 114.05%
Profit Quality 447.08%
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.93
F-Score6
WACC8.6%
ROIC/WACC1.33
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)318.5%
EPS 3Y3.25%
EPS 5YN/A
EPS Q2Q%154.04%
EPS Next Y47.66%
EPS Next 2Y38.47%
EPS Next 3Y29.49%
EPS Next 5YN/A
Revenue 1Y (TTM)9.63%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%2.11%
Revenue Next Year13.41%
Revenue Next 2Y14.01%
Revenue Next 3Y13.73%
Revenue Next 5Y-1.25%
EBIT growth 1Y81.45%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year70.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.81%
FCF growth 3YN/A
FCF growth 5Y58.54%
OCF growth 1Y-8.07%
OCF growth 3Y269.26%
OCF growth 5Y46.73%